cryptocurrency create Featured

The exposure of Xiaomi Auto to the sea is accelerated, and overseas sales will be carried out around the local Xiaomi Home store. Many sources say that Xiaomi Auto is preparing to build a car business to the sea. The international department of Xiaomi Group has added a preparation team for the sea sales business, and is recruiting positions such as market research, project management and electric vehicle after-sales engineers. Under the Ministry of Automobile, Xiaomi's autonomous driving department has added a number of jobs for overseas markets to solve the problem of overseas legal verification and function landing of autonomous driving function. It is foreseeable that autonomous driving will be one of the key points of Xiaomi Automobile's betting on the sea. The report quoted people familiar with the matter as saying that after the formation of the team, Xiaomi will sell small quantities of cars overseas in recent years to test the market reaction and prepare for the large-scale development of the sea business. The overseas sales of Xiaomi Automobile will mainly rely on the Xiaomi Home store under the International Department. At present, Xiaomi has more than 100 direct stores overseas. In July this year, Lei Jun replied, "When can I buy Xiaomi cars in France?" The goal is to sell Xiaomi brand cars in Europe before 2030. Judging from the speed of the formation of Xiaomi Auto's sea team, this progress is likely to be accelerated. (36Kr Auto)Zhendong Pharmaceutical has set up a new health management service company. The enterprise search APP shows that recently, Shanxi Zhendong Health Management Service Co., Ltd. was established, with Zhao Jin as the legal representative and a registered capital of 10 million yuan. Its business scope includes: remote health management services; Health consulting services (excluding medical services), etc. Enterprise investigation shows that the company is wholly owned by Zhendong Pharmaceutical.What is the significance of fiscal and monetary policy adjustment? Expert: The path of "more active and promising" fiscal policy has been clarified. The Central Economic Work Conference, which closed yesterday, pointed out that a more active fiscal policy and a moderately loose monetary policy should be implemented next year. What kind of signals are released behind these policies? In terms of fiscal policy, the Central Economic Work Conference requested that a more active fiscal policy should be implemented next year, so as to improve the fiscal deficit ratio, increase the issuance of ultra-long-term special government bonds, increase the issuance of special bonds for local governments, optimize the structure of fiscal expenditure, and secure the bottom line of "three guarantees" at the grassroots level. Experts said that these requirements clarified the path of "more active and promising" fiscal policy. Focusing on vigorously boosting consumption, the Central Economic Work Conference requires that special actions to boost consumption should be implemented next year, the basic pension for retirees should be appropriately raised, and the "two new" policies (large-scale equipment renewal and trade-in of consumer goods) should be implemented. (CCTV News)

Zhendong Pharmaceutical has set up a new health management service company. The enterprise search APP shows that recently, Shanxi Zhendong Health Management Service Co., Ltd. was established, with Zhao Jin as the legal representative and a registered capital of 10 million yuan. Its business scope includes: remote health management services; Health consulting services (excluding medical services), etc. Enterprise investigation shows that the company is wholly owned by Zhendong Pharmaceutical.Tongda shares: Huashengbaili plans to reduce its shareholding by no more than 3%. Datong shares announced that Huashengbaili, a shareholder holding more than 5%, plans to reduce its shareholding by centralized bidding and block trading within three months after 15 trading days from the disclosure date of this announcement, with a total shareholding of no more than 2.664 million shares, accounting for 3% of the company's total share capital.Ha Sanlian: Four kinds of drugs are planned to win the bid for national centralized procurement. Ha Sanlian announced that the company and its wholly-owned subsidiary Lanxi Pharmaceutical participated in the tenth batch of national centralized procurement of drugs organized by the state. The company's esmolol hydrochloride injection, pentoxifylline injection, potassium chloride injection, and tandospirone citrate tablets of Lanxi Pharmaceutical intend to win the bid for this centralized procurement. If the subsequent purchase contract is signed and implemented, it will help to expand the sales of related products and improve the market share and brand influence. The prices of the above-mentioned drugs are respectively 1.34 yuan for esmolol hydrochloride injection, 0.59 yuan for pentoxifylline injection, 0.16 yuan for potassium chloride injection and 6.56 yuan for tandospirone citrate tablets.

ST Mo Long and other materials companies have set up sales business of renewable resources. The enterprise search APP shows that recently, Shandong Cangyuan Materials Co., Ltd. was established, with Liu Shuai as the legal representative and a registered capital of 5 million yuan. Its business scope includes: sales of machinery and equipment; Sales of coal and products; Sales of renewable resources; Import and export agents, etc. Enterprise equity penetration shows that the company is jointly held by ST Mo Long and others.China Merchants Securities: Investment Guidelines of the Central Economic Work Conference for A-shares next year From these four aspects, China Merchants Securities said that the investment guidelines of the Central Economic Work Conference for A-shares next year mainly include the following aspects: 1) From a macro perspective, the support intensity of policies for various economic work is expected to exceed market expectations. Specifically, the fiscal policy orientation is positive, deficit ratio will arrange or keep it above 3%, the issuance scale of ultra-long-term special government bonds will be further expanded, and the scale and investment field of special bonds are expected to be further extended; Monetary policy mentioned "timely lowering the RRR and cutting interest rates", and the goal of liquidity policy changed from balance to loose tendency, which will bring room for valuation improvement of A shares. 2) From the perspective of expanding domestic demand, consumption will become the main line of investment next year: the meeting will continue the deployment of the Politburo meeting in December, and in the order of writing, consumption will still be placed at the top of next year's key tasks. In terms of specific measures, it is planned to boost consumption mainly through two aspects. First, increase the income of residents; The second is to increase consumption scenarios. 3) Focus on scientific and technological innovation to lead the development of new quality productive forces, and grasp two main lines: this meeting focused on "carrying out' artificial intelligence+'action and cultivating future industries". Artificial intelligence has appeared in the draft of the Central Economic Work Conference for three consecutive years. Future industries have also appeared in the draft of the Central Economic Work Conference for two consecutive years. Therefore, it is recommended to focus on artificial intelligence+and future industries. 4) Focus on "comprehensive improvement of' involution' competition": In terms of "involution" competition, photovoltaic industry is the representative in emerging industries. Recently, in addition to self-regulatory measures such as industry association initiatives, the photovoltaic export tax rebate rate has been lowered and industry norms have been updated to further control new production capacity. The policy is further introduced to curb the "involution" competition of photovoltaics. It is recommended to pay attention to photovoltaic, lithium battery and other industries.Yiwei lithium can pass the medical device quality management system certification (ISO 13485:2016). Yiwei lithium news, recently, Yiwei lithium can obtain the medical device quality management system certification (ISO 13485:2016) issued by DNV, and the certification scope includes the design, manufacture and sales of lithium batteries and secondary lithium batteries for medical devices. It indicates that Yiwei lithium can reach the international level in research and development, manufacturing and quality management of medical battery products.